Clinical Practice Session

Aging and Wasting in CKD

November 08, 2019 | 02:00 PM - 04:00 PM

Location: 144, Walter E. Washington Convention Center

Session Description

This session examines whether single eGFR and albuminuria thresholds should be used to define CKD in the young and old. It also discusses the effects of kidney function decline on cognitive function, potential interventions for frailty, and drug dosing in elderly patients with CKD.

Learning Objective(s)

  • Describe the rationale for the use of a single eGFR and albuminuria threshold to define CKD across different age groups
  • Summarize the experimental and clinical data on cognitive function decline and dementia in CKD
  • Discuss potential interventions for frailty in CKD and ESRD
  • Discuss drug dosing for CKD in elderly patients

Learning Pathway(s)

  • Chronic Kidney Disease
  • Dialysis

Moderators

  • Sarbjit Vanita Jassal, MD, PhD
  • Sankar D. Navaneethan, MD, MS, MPH, FASN

Presentations

  • Should the eGFR and Albumin/Creatinine Ratio Threshold for CKD Differ by Age and Sex?
    02:00 PM - 02:30 PM
    Josef Coresh, MD, PhD, FASN
  • CKD and Cognitive Function Decline
    02:30 PM - 03:00 PM
    Mark J. Sarnak, MD, MS
  • Frailty in CKD and ESRD: What Can Be Done About It?
    03:00 PM - 03:30 PM
    Kirsten L. Johansen, MD, FASN
  • Drug Dosing in Older Adults with CKD
    03:30 PM - 04:00 PM
    Joanna Q. Hudson, PharmD, FASN